Tackling Neurodegeneration in MS Through A1 Antibodies: Michael Levin, MD, FAAN, FANA - Neurology Live
6/1/2022 12:00:00 AM2 years 11 months ago
by Michael Levin, MD, FAAN, FANA
by Michael Levin, MD, FAAN, FANA
The professor of neurology at the University of Saskatchewan discussed his presentation at the 2022 CMSC Annual Meeting on using ribonucleoprotein A1 antibodies to drive neurodegeneration in multiple sclerosis. [WATCH TIME: 4 minutes]
WATCH TIME: 4 minutes "As we add these A1 antibodies to that model, nerve cells A1 are misplaced and nerve cells die. Then we take primary nerve cells isolated from mouse brain and showed the same t… [+1868 chars]
full article...